GGT5 and neoplasm: Interestingly, our study clearly confirmed that GGT5 specially expressed in CAFs, but not in tumor cells, which contributed to tumor cell proliferation and drug resistance by increasing intracellular GSH and reducing the intracellular ROS level in LUAD cells.